Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology


Por: Pérez-Segura P, Palacio JE, Vázquez L, Monereo S, de Las Peñas R, de Icaya PM, Grávalos C, Lecube A, Blasco A, García-Almeida JM, Barneto I, Goday A

Publicada: 1 jun 2017
Resumen:
The relationship between obesity and cancer is clear and is present at all times during course of the disease. The importance of obesity in increasing the risk of developing cancer is well known, and some of the most prevalent tumours (breast, colorectal, and prostate) are directly related to this risk increase. However, there is less information available on the role that obesity plays when the patient has already been diagnosed with cancer. Certain data demonstrate that in some types of cancer, obese patients tolerate the treatments more poorly. Obesity is also known to have an impact on the prognosis, favouring lower survival rates or the appearance of secondary tumours. In this consensus statement, we will analyse the scientific evidence on the role that obesity plays in patients already diagnosed with cancer, and the available data on how obesity control can improve the quality of daily life for the cancer patient.

Filiaciones:
Pérez-Segura P:
 Servicio de Oncología Médica, Hospital Clínico Universitario San Carlos, Calle Profesor Martín Lagos, s/n, 28040, Madrid, Spain.

Palacio JE:
 Servicio de Endocrinología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, Spain

Vázquez L:
 Servicio de Oncología Médica, Complejo Hospitalario de Pontevedra, Pontevedra, Spain

Monereo S:
 Servicio de Endocrinología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

de Las Peñas R:
 Servicio de Oncología Médica, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Castellón, Spain

de Icaya PM:
 Servicio de Endocrinología, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain

Grávalos C:
 Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain

Lecube A:
 Servicio de Endocrinología, Hospital Arnau de Vilanova, Lleida, Spain

Blasco A:
 Servicio de Oncología Médica, Consorcio Hospital General Universitario de Valencia, Valencia, Spain

García-Almeida JM:
 Servicio de Endocrinología, Hospital Universitario Virgen de la Victoria, Málaga, Spain

Barneto I:
 Servicio de Oncología Médica, Hospital Universitario Reina Sofía, Córdoba, Spain

Goday A:
 Servicio de Endocrinología, Hospital del Mar, Barcelona, Spain

 Departament de Medicina, IMIM Institut Mar de Investigacions Mediques, CiberOBN, Universitat Autònoma de Barcelona, Barcelona, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 19 Número: 6
Páginas: 682-694
WOS Id: 000401255400004
ID de PubMed: 28074400

MÉTRICAS